Navigation Links
IGY Immune Technology & Life Sciences Purchases Manufacturing Facility to Produce Purified Immunoglobulin Y (IgY)
Date:4/30/2012

THUNDER BAY, Ontario, April 30, 2012 /PRNewswire/ -- IGY Immune Technology & Life Sciences has acquired manufacturing capabilities to produce its proprietary IgY products.  IgY from chicken egg yolks has long been recognized among scientists for its immune enhancing benefits in humans as well as its ability to deliver customized antibodies to fight sickness and maintain good health.  Until now, a consistent, purified source has not been available commercially.  IGY Immune Technology & Life Sciences expects to be producing IgY by the end of 2012.

"The acquisition of this facility and our existing intellectual property position make IGY Immune Technology the world's leader in the production of IgY," said Terry Dyck, chief executive officer. "The production of IgY at higher purity levels and lower cost will create a number of product development opportunities across the nutrition, cosmetic, pharmaceutical and animal health industries."

The existing world supply of IgY is very limited and expensive.  IGY Immune Technology's unique process is able to produce commercial quantities of IgY from chicken egg yolk.  The manufacturing facility is in close proximity to major egg producers and the production process utilizes no toxic chemicals allowing the egg yolk to be returned back into the food supply.

IGY Immune Technology & Life Sciences is already in the commercialization process with its first product and has a number of business partnerships in development with major life sciences corporations.  An opportunity for investment in IGY Immune Technology is also available.

"We're establishing ourselves already with leading companies that have been following IgY developments," said Dyck.  "We're moving forward in securing these partnerships as well as providing a profitable opportunity for investors."

For more information about IGY Immune Technology & Life Sciences, visit its web site at: http://www.igylifesciences.com


'/>"/>
SOURCE IGY Immune Technology & Life Sciences
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Discovery in Nature elucidates immune cells in skin and supports novel vaccine approach
2. Argos Therapeutic Arcelis™ Immunotherapy AGS-003 in Combination With Sunitinib Shows Statistically Significant Correlation of Immune System Response to Overall Survival in Phase 2 Study in Patients with Advanced Renal Cell Carcinoma (RCC)
3. MU researchers identify key plant immune response in fight against bacteria
4. Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer
5. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
6. Immune Design Corp. and Sanofi-Aventis Announce Research Collaboration
7. Immune Design Corp. Appoints Guy F. Cipriani as Chief Business Officer
8. Alcohol-related behavior changes -- blame your immune system
9. Immune Deficiency Foundation Launches Free Accredited Course for Nurses About Primary Immunodeficiency and Immunoglobulin Therapy
10. New HIV vaccine approach targets desirable immune cells
11. David H. Murdock Research Institute Assumes Control of the Immune Tolerance Institute and Establishes a State of the Art Human Immune Monitoring Laboratory for Biomarker Discovery and Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... LONDON , Dec. 8, 2016 This report ... following Product Segments: Acid Based (Humic, Amino, & Fulvic), Extract ... by the following Crop Types: Ornamental & Turf, Row Crops, ... US, Canada , Japan ... , Latin America , and Rest of ...
(Date:12/8/2016)... -- OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS ... today announced financial results for the fiscal first ... on our commitment to address an unmet medical ... pleased with the early clinical response data presented ... focused on advancing our lead program – ImmunoPulse® ...
(Date:12/8/2016)... AskLinkerReports.com has published a report on ... Industry 2016 Market Research Report. From a basic outline of ... are all covered in the report. This report projects investment ... of the Amyloglucosidase industry. ... , , Complete ...
(Date:12/8/2016)... SAN DIEGO , Dec. 8, 2016 /PRNewswire-USNewswire/ ... treatments for congestive heart failure and type 2 ... license for a novel adeno-associated virus (AAV) vector ... Kay , M.D., Ph.D., at Stanford University. The ... of its paracrine gene therapy product pipeline. ...
Breaking Biology Technology:
(Date:11/29/2016)... , Nov. 29, 2016   ... identification and object recognition technologies, today released ... for fingerprint recognition solutions that run on ... fingerprint template using less than 128KB of ... compact devices that have limited on-board resources, ...
(Date:11/22/2016)... November 22, 2016 According to the new market ... Print, Face, Vein, Signature, Voice), Multi-Factor), Component (Hardware and Software), Function (Contact ... MarketsandMarkets, the market is expected to grow from USD 10.74 Billion in ... 16.79% between 2016 and 2022. Continue Reading ... ...
(Date:11/17/2016)... Global Market Watch: Primarily supported by ownership types; ... Academics) market is to witness a value of US$37.1 billion ... Compounded Annual Growth Rate (CAGR) of 10.75% is foreseen from ... 2014-2020. North America is not way ... Europe at 9.56% respectively. Report Focus: ...
Breaking Biology News(10 mins):